American Society of Hirudotherapy

Morphological data and DNA barcoding reveal the presence of the alien freshwater leech Helobdella octatestisaca (Hirudinida: Glossiphoniformes) in North Africa (Tunisia)

Species identification study published in Molecular Biology Reports (2024)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Basic science (non-clinical)Genomics & ProteomicsBen Ahmed R et al. · Molecular Biology Reports, 2024

Abstract

BACKGROUND: We hereby report the first occurrence of Helobdella octatestisaca in North Africa, specifically in Tunisia, as a likely introduced species from the Neotropical Region. Historically, leeches bearing a prominent chitinous scute on their dorsal surface were commonly diagnosed as H. stagnalis. Most probably, H. octatestisaca had previously been misidentified as H. stagnalis in Tunisia. METHODS AND RESULTS: The identification was primarily based on morphological evidence, supplemented by genetic data obtained from COI DNA barcoding. The morphology of the examined specimens was consistent with the original species description, notably characterized by the presence of four pairs of testisacs. To support our findings, we conducted a phylogenetic analysis using the Maximum Likelihood method based on COI alignment constructed with the newly obtained sequence from Tunisian specimens and complete or nearly complete 'Folmer fragment' sequences of congeners sourced from the GenBank database. CONCLUSIONS: This study highlights the first identification of H. octatestisaca in North Africa and suggests that previous records of H. stagnalis in Tunisia likely misidentified this species.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsPhylogenyLeechesDNA Barcoding, TaxonomicTunisiaFresh WaterIntroduced SpeciesElectron Transport Complex IV

Summary

This study reports the first, likely Neotropical-origin, occurrence of Helobdella octatestisaca in North Africa (Tunisia), where it was probably previously misidentified as H. stagnalis; identification relied on morphology, including four pairs of testisacs, and COI DNA barcoding.

Context

This study reports the first occurrence of the freshwater leech Helobdella octatestisaca in North Africa (Tunisia), likely an introduced species from the Neotropical Region, based on morphological evidence—including four pairs of testisacs consistent with the original species description—and COI DNA barcoding with Maximum Likelihood phylogenetic analysis. The authors suggest that previous Tunisian records of H. stagnalis likely represent misidentifications of H. octatestisaca. This is a taxonomic and biogeographic contribution documenting an alien freshwater leech species. H. octatestisaca is a non-medical freshwater leech, and the work addresses species distribution and identification.

Citation

Reference (Vancouver style)

Ben Ahmed R, Gajda Ł, Świątek P. Morphological data and DNA barcoding reveal the presence of the alien freshwater leech Helobdella octatestisaca (Hirudinida: Glossiphoniformes) in North Africa (Tunisia). Mol Biol Rep. 2024;51(1):1081. doi:10.1007/s11033-024-10004-x. PMID: 39432187

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.